Urbanitae closed 2024 with a record €213 million funded, up 60% from 2023, totaling €480 million since 2019. It completed 66 projects, mainly in Spain, with...
Looking ahead to 2024, the group plans to reach break-even, when the European Medicines Agency approves its drug against glioblastoma, an aggressive type of cancer that...